Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05088590 · ClinicalTrials.gov registry record · NA
Growing Up Formula Versus Nutritional Supplements: Effect on Catch up Growth, Micronutrient Status, and Solid Foods Intake in Toddlers With Mild or Moderate Malnutrition
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05088590: Completed NA study, sponsored by University of Colorado, Denver.
NCT05088590 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05088590, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This is a pilot study to test how a growing-up formula (GUF) compares to a common nutritional supplement (NS), which is regularly used to help toddlers (ages 12-36 months) gain weight. This study will look at whether GUF helps to increase solid food intake for children who are thought to be "picky eaters" and see the effects on growth compared with the NS. To date, it is not clear if GUFs help to increase intake of solid foods. Participants will be placed into one of the two study arms: Enfagrow (GUF) or Pediasure (standard NS).
Primary Outcome
1. Amount of intake of food groups from age-appropriate solid foods; 2. Intake of calories from age-appropriate solid foods; 3. Intake of micronutrients from age-appropriate solid foods; 4. Proportion of calories consumed from age-appropriate solid foods compared with the assigned supplement; 5. Proportion of micronutrients consumed from age-appropriate solid foods compared with the assigned supplement
Interventions
- DIETARY_SUPPLEMENT Enfagrow® Neuropro Toddler Nutritional Drink
- DIETARY_SUPPLEMENT Pediasure® Grow & Gain Protein Shake for Kids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-08-27 |
| Est. Completion | 2024-12-01 |
| Phase | NA |
What the finished NCT05088590 record still lists
NCT05088590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Enfagrow® Neuropro Toddler Nutritional Drink is the first listed.
NCT05088590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05088590 about?
NCT05088590 is a clinical study titled "Growing Up Formula Versus Nutritional Supplements: Effect on Catch up Growth, Micronutrient Status, and Solid Foods Intake in Toddlers With Mild or Moderate Malnutrition". This is a pilot study to test how a growing-up formula (GUF) compares to a common nutritional supplement (NS), which is regularly used to help toddlers (ages 12-36 months) gain weight. This study will look at whether GUF helps to increase solid food intake for children who are thought to be "picky e...
What is the current status of trial NCT05088590?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2021-08-27. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT05088590?
The interventions under investigation include: Enfagrow® Neuropro Toddler Nutritional Drink (DIETARY_SUPPLEMENT), Pediasure® Grow & Gain Protein Shake for Kids (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05088590?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05088590's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI